Millions still lack access to sight-restoring cataract surgery 🌍👁️
Modi Naftali, MD shares how robotics + AI could empower surgeons, expand access, and standardize outcomes worldwide.
Read more: https://ow.ly/2gFx50YhFM8
#Ophthalmology #CataractSurgery #GlobalHealth #MedTech
Difficult patient conversations are inevitable. How we respond makes all the difference.
Savory Turman, shares practical communication strategies that help ophthalmic teams defuse tension, build trust, and create connection.
Read more: https://ow.ly/7ck050Y81Oi
#Ophthalmology
👀 CMS just opened the door wider for at-home vision monitoring with new RPM codes and clearer reimbursement for home OCT.
Earlier detection, smarter care between visits, and more sustainable payment models may finally be here 🔗 https://ow.ly/Qnkb50Ycazc
#VisionCare #EyeHealth
Burnout doesn’t always hit all at once. Sometimes it’s stress, exhaustion, or even losing interest in the work you once loved.
Amanda Waggoner, COMT, shares how to recognize burnout early and take small steps to refill your bucket: https://ow.ly/J8iU50Yca9S
#Ophthalmology
Nearly half of people facing cataract blindness worldwide still lack access to surgery, according to new data cited by WHO.
In Africa, 3 in 4 who need surgery go untreated, and women face lower access globally.
👉 Read more: https://ow.ly/N6hB50Yh90B
#Ophthalmology
Great cataract outcomes start with great education.
Christine Sykora shares best practices for educating surgical cataract patients before, during, and after the visit to reduce anxiety, improve efficiency, and boost satisfaction.
Read more: https://ow.ly/MxIz50Y820A
#Cataract
Thinking about AI tools for your practice?
Fraud & abuse risk, FDA regulation, and the Practice Fusion case all matter more than ever for ophthalmology. Learn what to watch for before adopting clinical decision support tools 👁️
Read more:
https://ow.ly/bvbW50Y5gTM
#Ophthalmology
Happy International Day of Women and Girls in Science 👩🔬
Julie Brewer of Alcon shares why mentorship matters, plus insights on digital innovation and the future of eye care across cataract, retina, and vision care.
Read the full interview: https://ow.ly/y65350Ycbb4
#WomenInScience #WomenInSTEM
Gene therapy innovation in geographic atrophy is moving forward.
ZipBio and MeiraGTx have entered an exclusive license agreement to advance AI-designed gene therapies targeting the complement pathway for GA.
👉 Learn more: https://ow.ly/3xJc50YbAL0
#GeneTherapy
Aeye Health has just expanded its Epic EMR integration, enabling primary care providers, endocrinologists, and diabetes centers to perform AI-powered diabetic retinopathy exams in under one minute with real-time results.
Read more: https://ow.ly/66tz50Y9QBe
#AIInHealthcare
A routine cataract case can quickly become complex with IFIS.
In this article, Axel Rivas, BS, Michelle L. Huynh, MD, and Claire Wright, MD share a real-world case and practical strategies for managing floppy iris syndrome.
👉 https://ow.ly/3B2V50Y0FR4
#Ophthalmology #CataractSurgery
Post-LASIK patients are coming back for cataract surgery and they are driving premium IOL adoption.
Dr. Mark Kontos breaks down why this growing demographic delivers outsized ROI and how to prepare your practice for the wave ahead 👁️
Read more: https://ow.ly/698H50Y4OGL
#Cataract
🧬 Targeted therapy is changing the future of TED care.
Thomas A. Ciulla, MD, MBA explains how advances in TED pathophysiology - especially IGF-1R targeting - have transformed treatment from symptom control to disease modification.
👉 Read more: https://ow.ly/1Mq150Y0vUI
#TEDCare #OncologyResearch
👁🗨Just in! The FDA has approved Yuvezzi, the first dual-agent eye drop for presbyopia.
The carbachol and brimonidine combo showed significant near vision improvement with favorable tolerability in phase 3 trials.
Read more: https://ow.ly/45N150Y5qJW
#Presbyopia #Ophthalmology #FDAApproval
New data show Qlosi 0.4% significantly reduced pupil size while maintaining ciliary muscle movement similar to control. Imaging results support pupil selectivity in presbyopic eyes 👁️🔬
Learn more about the study: https://ow.ly/U2ah50Y4KbT
#Presbyopia #EyeCare #Ophthalmology
A milestone for retinal innovation.
OpCT-001 has received FDA Orphan Drug Designation for retinitis pigmentosa, highlighting increasing industry focus on regenerative and cell-based approaches for inherited photoreceptor diseases.
👉 Read the full update: https://ow.ly/YsYA50Y49fH
#Retina
New launch 💧 Focus Vitamins introduces Focus Tears PF Eye Drops - preservative-free, single-dose artificial tears for fast, soothing dry eye relief at home or on the go.
👉 Read more: https://ow.ly/FMIQ50Y0wmu
#DryEye #EyeHealth #PreservativeFree
🔹 Leadership is influence - not a title.
In this article, Mandy Cansler, explains how technicians build trust, shape culture, and lead from the trenches through initiative, accountability, and curiosity.
👉 Read the full article: https://ow.ly/8w1A50XWG4M
#Ophthalmology
🚨 Modifier -25 is under the microscope - again.
Mary Pat Johnson, reviews CMS guidance, real-world case studies, and documentation requirements to help practices avoid costly mistakes.
👉 Read the full article: https://ow.ly/oO0r50XWFSQ
#MedicalCoding #CMSGuidance
Dr. Reddy’s launches FDA-approved OTC generic of Extra-Strength Pataday (olopatadine 0.7%) in the US, expanding options for allergy-related itchy eye relief.
Read more: https://ow.ly/WTGV50Y09GO
#Ophthalmology #EyeCare
🚨 Breakthrough in Infantile Nystagmus
New RCT data published in BJO shows RevitalVision significantly improves visual acuity, contrast sensitivity & functional vision - with nearly half of patients reaching 20/40.
👉 Read the study: https://ow.ly/3sNk50XWCVf
#Ophthalmology
💡 Interventional glaucoma is a philosophy - not just a procedure.
In this article, Melissa Ciccarelli, COE shares how practices can reduce barriers, align teams, and shift toward earlier glaucoma intervention.
👉 Read the full article: https://ow.ly/8Sxo50XWFJE
#Glaucoma #Ophthalmology
🚨 FDA clearance alert
Rayner’s Sophi Phaco System has received FDA clearance!
The Swiss-engineered platform is designed for faster setup, quicker patient turnover, and greater mobility across ASCs, offices, and hospitals
👉 Read more https://ow.ly/OX6o50XWGxm
#Ophthalmology
🎉 Celebrating 30 years of Ophthalmology Management
This year marks 30 years of supporting ophthalmologists at the intersection of clinical care, surgical innovation, and practice. Thank you to our editorial teams, contributors, and readers for being part of this journey.
🔗 https://ow.ly/zrbw50XWbuc
Post-op outcomes start before surgery. 👁️
Vance Thompson, MD shares why optimizing the ocular surface pre- and post-op can reduce STODS and improve visual quality and patient satisfaction.
https://ow.ly/LAm750XN580
#Ophthalmology #OcularSurface #CataractSurgery
Tight budget, high ROI expectations?
Amanda Robben, COE shares practical marketing moves for eye care practices: shift to trackable channels, post with purpose, focus on retention, and run low-cost patient education events.
Read more: https://ow.ly/nvgC50XN536
#Ophthalmology
New international myopia guidance is here. 🌍
The IMI 2025 Digest urges early, personalized care, highlighting hyperopic reserve, outdoor time, and proactive intervention to delay onset and improve long-term outcomes.
Read here: https://ow.ly/FWym50XRQ9F
#Myopia #EyeCare
Private equity or private practice? Many ophthalmologists are weighing the trade-offs.
This article explores both sides, from autonomy and patient relationships to scale, support, and work-life balance, with insights from ophthalmologists.
🔗 https://ow.ly/UIhu50XN4Y2
#Ophthalmology
👁️ Here's everything you've missed in the news!
From clinical trial milestones and FDA updates to innovations in AI, retina, and cataract care, the Ophthalmology Management News hub rounds up the stories that mattered most in 2025.
Start 2026 informed.📰
👉 https://ow.ly/mhZL50XM9XF
#Ophthalmology
Okyo reports favorable corneal nerve data in phase 2 study
Patients treated with 0.05% urcosimod demonstrated a positive reduction in neuropathic corneal pain, & favorable changes in corneal nerve structure that were not observed in the placebo group.
🔗 https://ow.ly/oTNG50XN4SA
#Ophthalmology
